RT Journal Article
SR Electronic
T1 Sociodemographic Barriers to the Timely Treatment of Pancreatic Cancer
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 4969
OP 4974
DO 10.21873/anticanres.16695
VO 43
IS 11
A1 PAOLA BERRIOS JIMENEZ
A1 REED POPP
A1 SEEMA SHARAN
A1 HARSHEEN K. MANAISE
A1 SYEDA HOORULAIN AHMED
A1 SHIVAM BANSAL
A1 GABRIELLE KOWKABANY
A1 SWATHI RAIKOT
A1 KULKAEW BELLE SUKNIAM DO
A1 ANTHONY GEORGE
A1 EMMANUEL GABRIEL
YR 2023
UL http://ar.iiarjournals.org/content/43/11/4969.abstract
AB Background/Aim: Pancreatic cancer has a high mortality rate and timely treatment is imperative for favorable patient outcomes. This retrospective study aimed to identify disparities in time to treatment for pancreatic cancer based on sociodemographic factors. Patients and Methods: The study used the National Cancer Database from 2004 to 2019. A total of 423,482 patients with pancreatic cancer were included in the study. Time to first treatment, surgery, radiation, and chemotherapy were analyzed in the context of age, sex, race, Hispanic origin, insurance status, income, facility type, geographic setting, grade, stage, and Charlson-Deyo Comorbidity score (CDC). Results: All sociodemographic factors included were found to be significantly associated with disparities for time to treatment in at least one of the categories studied. Minorities, treatment at academic facilities, and patients with a high CDC score had consistently longer times to all treatment classifications. Conclusion: The analyzed sociodemographic factors affected time to pancreatic cancer treatment. Disparities in time to treatment for pancreatic cancer must be studied and understood to ameliorate the impact this cancer has on society and assure the best possible care for all communities.